Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes
1996

Changes in Syndecan-1 During Tumor Progression in Colonic Cells

publication Evidence: moderate

Author Information

Author(s): P Levy, A Munier, S Baron-Delagel, Y Di Gioia, C Gespach, J Capeau, G Cherqui

Primary Institution: INSERM-U.402, Faculte de Medecine Saint-Antoine, Paris, France

Hypothesis

The study aims to determine if tumorigenic progression in Caco-2 cells induced by oncogenes is associated with specific alterations of syndecan-1.

Conclusion

The study found that oncogenic activation of Caco-2 cells leads to significant changes in syndecan-1 expression and its ectodomain characteristics.

Supporting Evidence

  • Oncogene-transfected Caco-2 cells showed decreased syndecan-1 protein expression without changes in mRNA levels.
  • Alterations in syndecan-1 ectodomain included reduced glycosaminoglycan chain length and sulphation.
  • Both oncogenes induced similar changes in syndecan-1 expression, suggesting a common pathway in tumorigenesis.

Takeaway

When certain genes that cause cancer are activated in colon cells, the way these cells express a protein called syndecan-1 changes, which might affect how they grow and spread.

Methodology

Caco-2 cells were transfected with oncogenes and analyzed for syndecan-1 expression and ectodomain characteristics using biochemical assays.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication